Trial · NCT07125625
Probiotic Mixture (L. Rhamnosus GG and L. Plantarum 299V) In Pediatric Irritable Bowel Syndrome
What is this study about? This clinical study aims to investigate whether a specific combination of probiotics-Lactobacillus rhamnosus GG and Lactobacillus plan
- Status
- Recruiting
- Sponsor
- University of Bari
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 124 participants (planned)
- Start
- Oct 27, 2025
- Primary completion
- Jun 30, 2027
- Conditions
- Irritable Bowel Syndrome (IBS)
Summary
What is this study about? This clinical study aims to investigate whether a specific combination of probiotics-Lactobacillus rhamnosus GG and Lactobacillus plantarum 299V-can help children and adolescents with Irritable Bowel Syndrome (IBS). IBS is a common digestive condition in children, causing abdominal pain, bloating, and changes in bowel habits (either diarrhoea, constipation, or alternating between the two). These symptoms can seriously affect a child's daily life and wellbeing.
Interventions
- Experimental arm: probiotic Dietary supplement
- Placebo Dietary supplement
Locations
1 country: Italy.
| Facility | City | Country |
|---|---|---|
| Pediatria Trambusti | Bari, Bari | Italy |
| University Of Bari Aldo Moro | Bari, BA | Italy |
| University of Udine-Pediatric Section | Udine, UD | Italy |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.